Human Skin Cells (Dermal Fibroblasts) cDNA (AVM)

SKU
ASD-9037
Model
ASD-9037
Size
20 rxns/vial
$693.00

Catalog Number ASD-9037
Quantity 20 reactions

Product Information
Description
Applied StemCell’s cDNA is synthesized from a highly pure and intact total RNA that was isolated via a modified guanidine thiocyanate technique and devoid of genomic DNA contamination. Five ug of total RNA was reverse transcribed into a single strand cDNA using oligo–dT primer in 20 mL total volume. RT reaction was stopped by heating at 85°C for 5 minutes. Using 1 µl of cDNA per PCR reaction is sufficient for 20 typical PCRs. Applied StemCell’s  cDNA can be used in gene expression and cloning studies, analysis of mRNA alternative splicing, gene mutation analysis and other molecular biology fields.
Fibroblasts are isolated from an individual who has been clinically diagnosed with arteriovenous malformation (AVM). AVM is an abnormal connection between veins and arteries, usually congenital.
Origin Human, single donor
Development Period Postnatal
Disease State Arteriovenous Malformation (AVM)
Test Conditions Quality of RNA used in cDNA synthesis is determined visually, analyzing 18S and 28S ribosomal bands by non-denaturing agarose gel electrophoresis. The RNA purity level is determined by spectrophotometry to obtain the A260/A280 ratio, which must range from 1.8-2.1. The RNA used in cDNA synthesis is treated with RNase-free DNase to remove any genomic DNA and is tested as DNA free by RT-PCR. The cDNA functionality is assayed by RT-PCR using primers for housekeeping gene GAPDH.